Evrard Kouamé Yao*,Gnakouri Alain Pacome Gnabro,Tawakaltu Bolasade Adebayo,Legnima Sekou Michel Tuo,Bitti Adé Odo,Donafologo Daouda Yeo,N’Zibla Marie Ange Yebouet,Noel Coulibaly
Issue:
Volume 9, Issue 1, June 2025
Pages:
1-6
Received:
9 December 2024
Accepted:
18 December 2024
Published:
16 January 2025
DOI:
10.11648/j.ijcu.20250901.11
Downloads:
Views:
Abstract: Background: Radical prostatectomy (RP) is the gold standard treatment for localised prostate cancer. It is performed at a low rate because of the difficulty in selecting patients. Patients are generally diagnosed at the metastatic stage. In the Ivorian literature, there are few reports on RP. We propose to describe an initial series. Objective: The aim of our study was to report the carcinological results of radical prostatectomy at Treichville University Hospital. Methods: We conducted a retrospective cohort from August 2019 to March 2023 at the Urology Department of Treichville University Hospital. We included all patients who had radical prostatectomy after being diagnosed with localised prostate cancer. Results: A total of 20 cases were selected. The mean age was 61.5 years. The most common Gleason score was 6 (3+3). 50% of patients were classified as pT3 and had a positive resection margin. Biological recurrence was observed in 75% of cases with positive resection margins after 6 months' follow-up. A 12-month recurrence-free survival analysis curve of the Klaplan Meier type was performed. Conclusion: The pT3 stage was associated with a positive resection margin and favoured biological recurrence. Later, we will expand the cohort. We are considering a research protocol on long-term functional outcomes.
Abstract: Background: Radical prostatectomy (RP) is the gold standard treatment for localised prostate cancer. It is performed at a low rate because of the difficulty in selecting patients. Patients are generally diagnosed at the metastatic stage. In the Ivorian literature, there are few reports on RP. We propose to describe an initial series. Objective: The...Show More